Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke.

Gerschenfeld G, Muresan IP, Blanc R, Obadia M, Abrivard M, Piotin M, Alamowitch S.

JAMA Neurol. 2017 Mar 20. doi: 10.1001/jamaneurol.2016.5823. [Epub ahead of print]

PMID:
28319240
2.

Successful Reperfusion With Mechanical Thrombectomy Is Associated With Reduced Disability and Mortality in Patients With Pretreatment Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score ≤6.

Desilles JP, Consoli A, Redjem H, Coskun O, Ciccio G, Smajda S, Labreuche J, Preda C, Ruiz Guerrero C, Decroix JP, Rodesch G, Mazighi M, Blanc R, Piotin M, Lapergue B; ETIS (Endovascular Treatment in Ischemic Stroke) Research Investigators..

Stroke. 2017 Feb 24. pii: STROKEAHA.116.015202. doi: 10.1161/STROKEAHA.116.015202. [Epub ahead of print]

PMID:
28235960
3.

Intracerebral hemorrhage location and outcome among INTERACT2 participants.

Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS; INTERACT2 Investigators..

Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003771. doi: 10.1212/WNL.0000000000003771. [Epub ahead of print]

PMID:
28235817
4.

Cerebral Fat Embolism in Hemoglobin SC Disease.

Scheifer C, Lionnet F, Bachmeyer C, Stankovic-Stojanovic K, Georgin-Lavialle S, Alamowitch S, Marro B, Mattioni S.

Am J Med. 2017 Feb 9. pii: S0002-9343(17)30120-1. doi: 10.1016/j.amjmed.2017.01.020. [Epub ahead of print] No abstract available.

PMID:
28189467
5.

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Leys D, Hommet Y, Jacquet C, Moulin S, Sibon I, Mas JL, Moulin T, Giroud M, Sagnier S, Cordonnier C, Medeiros de Bustos E, Turc G, Ronzière T, Bejot Y, Detante O, Ouk T, Mendyk AM, Favrole P, Zuber M, Triquenot-Bagan A, Ozkul-Wermester O, Montoro FM, Lamy C, Faivre A, Lebouvier L, Potey C, Poli M, Hénon H, Renou P, Dequatre-Ponchelle N, Bodenant M, Debruxelles S, Rossi C, Bordet R, Vivien D; OPHELIE investigators and the STROKAVENIR network..

Neurology. 2016 Dec 6;87(23):2416-2426.

PMID:
27815401
6.

Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature.

Laurent C, Capron J, Quillerou B, Thomas G, Alamowitch S, Fain O, Mekinian A.

Autoimmun Rev. 2016 Dec;15(12):1129-1133. doi: 10.1016/j.autrev.2016.09.008. Review.

PMID:
27639840
7.

Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: A frequent association?

Chardain A, Mesnage V, Alamowitch S, Bourdain F, Crozier S, Lenglet T, Psimaras D, Demeret S, Graveleau P, Hoang-Xuan K, Levy R.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):384-8. doi: 10.1016/j.neurol.2016.06.004.

PMID:
27371132
8.

Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.

Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB; PATCH Investigators..

Lancet. 2016 Jun 25;387(10038):2605-13. doi: 10.1016/S0140-6736(16)30392-0.

PMID:
27178479
9.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.

Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS; SOCRATES Steering Committee and Investigators..

N Engl J Med. 2016 Jul 7;375(1):35-43. doi: 10.1056/NEJMoa1603060.

10.

'The Move', an innovative simulation-based medical education program using roleplay to teach neurological semiology: Students' and teachers' perceptions.

Roze E, Flamand-Roze C, Méneret A, Ruiz M, Le Liepvre H, Duguet A, Renaud MC, Alamowitch S, Steichen O.

Rev Neurol (Paris). 2016 Apr-May;172(4-5):289-94. doi: 10.1016/j.neurol.2016.02.007.

PMID:
27062294
11.

Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies.

Carcel C, Sato S, Zheng D, Heeley E, Arima H, Yang J, Wu G, Chen G, Zhang S, Delcourt C, Lavados P, Robinson T, Lindley RI, Wang X, Chalmers J, Anderson CS; Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Investigators..

Crit Care Med. 2016 Jul;44(7):1388-94. doi: 10.1097/CCM.0000000000001628.

PMID:
26958746
12.

Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage.

Zheng D, Sato S, Arima H, Heeley E, Delcourt C, Cao Y, Chalmers J, Anderson CS; INTERACT2 Investigators..

Am J Kidney Dis. 2016 Jul;68(1):94-102. doi: 10.1053/j.ajkd.2016.01.020.

13.

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.

O'Connor P, Comi G, Freedman MS, Miller AE, Kappos L, Bouchard JP, Lebrun-Frenay C, Mares J, Benamor M, Thangavelu K, Liang J, Truffinet P, Lawson VJ, Wolinsky JS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas..

Neurology. 2016 Mar 8;86(10):920-30. doi: 10.1212/WNL.0000000000002441. Erratum in: Neurology. 2016 Oct 4;87(14 ):1524.

14.

Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study.

Zheng D, Arima H, Sato S, Gasparrini A, Heeley E, Delcourt C, Lo S, Huang Y, Wang J, Stapf C, Robinson T, Lavados P, Chalmers J, Anderson CS; INTERACT2 investigators..

PLoS One. 2016 Feb 9;11(2):e0149040. doi: 10.1371/journal.pone.0149040.

15.

Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage.

Sato S, Delcourt C, Zhang S, Arima H, Heeley E, Zheng D, Al-Shahi Salman R, Stapf C, Tzourio C, Robinson T, Lindley RI, Chalmers J, Anderson CS; INTERACT2 Investigators..

Cerebrovasc Dis. 2016;41(1-2):80-6. doi: 10.1159/000442532.

PMID:
26671408
16.

Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial.

Sato S, Arima H, Heeley E, Hirakawa Y, Delcourt C, Lindley RI, Robinson T, Huang Y, Morgenstern L, Stapf C, Wang J, Chalmers J, Anderson CS; INTERACT2 Investigators..

Cerebrovasc Dis. 2015;40(3-4):114-20. doi: 10.1159/000434690.

17.

[An update on limitations of intravenous thrombolysis to treat acute ischemic stroke].

Masingue M, Alamowitch S.

Presse Med. 2015 May;44(5):515-25. doi: 10.1016/j.lpm.2014.07.027. Review. French.

PMID:
25697630
18.

Strokes in Sneddon syndrome without antiphospholipid antibodies.

Bottin L, Francès C, de Zuttere D, Boëlle PY, Muresan IP, Alamowitch S.

Ann Neurol. 2015 May;77(5):817-29. doi: 10.1002/ana.24382.

PMID:
25628239
19.

Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2.

Sato S, Heeley E, Arima H, Delcourt C, Hirakawa Y, Pamidimukkala V, Li Z, Tao Q, Xu Y, Hennerici MG, Robinson T, Tzourio C, Lindley RI, Chalmers J, Anderson CS; INTERACT Investigators., Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang LJ, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1319-23. doi: 10.1136/jnnp-2014-309870.

PMID:
25589782
20.

Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2.

Arima H, Heeley E, Delcourt C, Hirakawa Y, Wang X, Woodward M, Robinson T, Stapf C, Parsons M, Lavados PM, Huang Y, Wang J, Chalmers J, Anderson CS; INTERACT2 Investigators.; INTERACT2 Investigators..

Neurology. 2015 Feb 3;84(5):464-71. doi: 10.1212/WNL.0000000000001205.

Supplemental Content

Loading ...
Support Center